| Ytd | 35.14% | |
| 1y | 156.26% |
| Open | 44.94 | Prev Close | 45.28 | Low | 44.16 | High | 45.66 | Mkt Cap | 2.60B |
| Vol | 1.12M | Avg Vol | 1.24M | EPS | -0.67 | P/E | N/A | Forward P/E | 64.57 |
| Beta | 1.16 | Short Ratio | 4.24 | Inst. Own | 90.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 01-27 | Earning | 10-28 | 50-d Avg | 45.16 | 200-d Avg | 38.25 | 1yr Est | 53.90 |
AXGN News
Axogen Inc. (NASDAQ:AXGN) on Thursday agreed to acquire a privately held medical device manufacturer
Axogen is acquiring BioCircuit Technologies for $200 million to add sutureless NerveTape to its port
Medical-device stocks Cooper Companies Inc (NASDAQ:COO) and Axogen Inc (NASDAQ:AXGN) are both sharpl
Axogen, Inc. (AXGN) M&A Call Transcript
Axogen, Inc. ("Axogen" or the "Company") (NASDAQ:AXGN), a global leader in developin
At closing, $1.0 million of the estimated merger consideration will be withheld pending determinatio
ALACHUA, Fla. and TAMPA, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (“Axogen” or the “Com
Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, bro
ALACHUA, Fla. and TAMPA, Fla.
On August 26, 2026, Axogen Inc (AXGN) shares rose 3.3% to a current price of $51.58, continuing a st
Truist Securities analyst Ravi Misra initiates coverage on Axogen (NASDAQ:AXGN) with a Buy rating
Wall Street analysts are reshuffling their bets ahead of a critical inflation report and NVIDIA earn
Axogen is transforming from a niche tissue supplier into a comprehensive nerve care platform, underp
Canaccord Genuity analyst Caitlin Roberts maintains Axogen (NASDAQ:AXGN) with a Buy and raises th
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises
HC Wainwright & Co. analyst Yi Chen maintains Axogen (NASDAQ:AXGN) with a Buy and raises the
AxoGen, Inc. (NASDAQ: AXGN - Get Free Report)'s stock price gapped down prior to trading on Wednesda
Axogen, Inc. (AXGN) Q2 2026 Earnings Call Transcript
AxoGen NASDAQ: AXGN reported second-quarter 2026 revenue of $69.7 million, up 23.1% from a year earl
AxoGen (AXGN) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estim
Nerve Trace is a near-infrared fluorescence imaging technology designed to provide direct, real-time
/PRNewswire/ -- Trace Biosciences, Inc., a clinical-stage biotechnology company developing nerve-tar
Axogen (NASDAQ:AXGN) reported quarterly earnings of $0.12 per share which missed the analyst consens
ALACHUA, Fla. and TAMPA, Fla.
ALACHUA, Fla. and TAMPA, Fla. , July 15, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a glo
AxoGen, Stock Of the Day, is flashing a buy signal. Ten out of 10 analysts are bullish about AxoGen
AxoGen NASDAQ: AXGN President and CEO Michael Dale said the company's growth strategy remains center
Axogen, Inc. (AXGN) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks T
U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimate
Axogen stock fell Thursday with a session volume of 1.92 million, priced its upsized underwritten pu
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
During the session on Thursday, 461 stocks hit new 52-week lows.
Friday's session saw 169 companies set new 52-week lows.